Role of Uterine Artery doppler
- Preeclampsia
- Fetal Growth Restriction (FGR)
- Placental insufficiency
Patient Preparation
Technique
Interpretation
Clinical Use
Parameter | Normal Range | Clinical Interpretation |
---|---|---|
Pulsatility Index (PI) | < 2.5 (mean ~1.5–2.3) | Elevated PI (>95th percentile) may suggest impaired placental perfusion |
Resistance Index (RI) | 0.45–0.80 | RI > 0.80 may indicate increased resistance in uterine arteries |
Peak Systolic Velocity (PSV) | 50–70 cm/s | Normal range; may vary depending on gestational age and equipment sensitivity |
A-wave (in uterine artery waveform) | Forward flow (positive A-wave) | Absent or reversed A-wave suggests increased downstream resistance or abnormal placental implantation |
Note: Bilateral uterine artery notching and elevated PI (>95th percentile) are associated with increased risk of early-onset preeclampsia, placental insufficiency, and fetal growth restriction (FGR).
These indices are often plotted against gestational age-based reference charts or MoMs (Multiples of Median) for interpretation.
Condition | Explanation |
---|---|
Early-onset Preeclampsia (PE) | High PI (>95th percentile) reflects increased resistance in uterine arteries, which is a key marker for predicting early PE. |
Fetal Growth Restriction (FGR / IUGR) | Poor placental blood flow leads to inadequate fetal nutrition and oxygenation, resulting in restricted growth. |
Placental Insufficiency | Impaired remodeling of spiral arteries causes high-resistance flow, leading to a dysfunctional placenta. |
Increased Risk of IUFD (Intrauterine Fetal Demise) | In severe cases, poor placental perfusion may result in fetal demise. |
Action | Details |
---|---|
Follow-up Anomaly Scan | Schedule a detailed fetal anomaly scan at 18–22 weeks to assess structural development. |
Serial Growth Monitoring | Conduct regular fetal biometry scans during 2nd and 3rd trimesters to monitor growth trends. |
Aspirin Prophylaxis | Start low-dose aspirin (75–150 mg daily) before 16 weeks to reduce the risk of preeclampsia. |
Monitor Preeclampsia Signs | Track maternal blood pressure, check for proteinuria, and observe for clinical symptoms. |
Specialist Referral | Refer to a maternal-fetal medicine (MFM) specialist if high-risk or severe findings are present. |
Aspect | Explanation |
---|---|
Normal Trophoblastic Invasion | Suggests good placental development due to adequate remodeling of spiral arteries and reduced vascular resistance. |
Low Risk of Preeclampsia or FGR | Associated with a lower likelihood of early-onset preeclampsia, fetal growth restriction (FGR), or placental insufficiency. |
Good Uteroplacental Perfusion | Indicates efficient blood flow from mother to placenta, supporting optimal fetal development. |
No Immediate Concern | Typically requires no intervention if other screening parameters (NT, DV flow, PAPP-A, etc.) are normal. |
Note: Interpretation should always be in context—combine with NT thickness, serum markers (PAPP-A, free Ξ²-hCG), ductus venosus flow, and clinical risk factors.
Clinical Interpretation of High Uterine Artery RI (> 0.80)
Condition | Explanation |
---|---|
Increased Uterine Vascular Resistance | High RI reflects restricted blood flow in uterine arteries, typically due to inadequate trophoblastic invasion and spiral artery remodeling. |
Risk of Early-Onset Preeclampsia | Elevated RI is a predictor of impaired placental perfusion and increased risk for preeclampsia, especially when combined with other markers. |
Fetal Growth Restriction (FGR / IUGR) | Inadequate maternal blood supply to the placenta may result in poor fetal growth. |
Placental Insufficiency | Persistent high resistance indicates poor uteroplacental circulation and inefficient nutrient/oxygen exchange. |
Increased Likelihood of Abnormal Doppler Findings Later | May correlate with uterine artery notching and abnormal PI or A-wave later in pregnancy. |
Note:
High RI alone should not be used in isolation—always interpret alongside:
- Uterine artery PI and A-wave
- NT thickness
- Biochemical markers (PAPP-A, free Ξ²-hCG)
- Maternal clinical risk factors
Clinical Interpretation of Low Uterine Artery RI (< 0.40–0.45)
Aspect | Explanation |
---|---|
Good Spiral Artery Remodeling | Low RI indicates reduced resistance in uterine arteries, reflecting normal trophoblastic invasion and placental development. |
Low Risk of Preeclampsia or FGR | Associated with decreased likelihood of uteroplacental insufficiency, preeclampsia, and fetal growth restriction. |
Optimal Uteroplacental Perfusion | Suggests healthy maternal blood flow to the placenta, supporting normal fetal growth and development. |
No Immediate Concern | Low RI alone is not considered pathological; typically no intervention needed if other parameters (PI, NT, PAPP-A) are normal. |
Note:
Interpretation should always be done in context—combine RI findings with:
- Uterine artery PI and presence of early diastolic notch
- NT measurement
- Serum markers (PAPP-A, free Ξ²-hCG)
- Ductus venosus Doppler
- Maternal clinical history and risk factors
Clinical Interpretation of Absent or Reversed A-Wave in Uterine Artery Doppler (11–13+6 Weeks)
Condition | Explanation |
---|---|
Impaired Spiral Artery Remodeling | Absent or reversed A-wave reflects high resistance and poor transformation of spiral arteries by invading trophoblasts. |
Early Marker of Placental Insufficiency | This waveform abnormality is associated with compromised placental perfusion and may precede other signs of dysfunction. |
High Risk of Early-Onset Preeclampsia (PE) | Strongly linked to increased risk of early-onset PE, particularly when combined with high PI/RI and low PAPP-A. |
Fetal Growth Restriction (FGR/IUGR) | May indicate insufficient maternal blood flow to the placenta, increasing the risk of restricted fetal growth and hypoxia. |
Possible Indication for Prophylaxis | Low-dose aspirin initiated before 16 weeks may help reduce risk of PE and improve outcomes in high-risk cases. |
Clinical Note:
Absent or reversed A-wave should always be interpreted in combination with:
- Uterine artery PI and RI
- NT measurement
- Serum markers (PAPP-A, free Ξ²-hCG)
- Ductus venosus flow
- Maternal risk factors (e.g., history of PE, chronic hypertension, autoimmune conditions)
No comments:
Post a Comment